logo

Agios Pharmaceuticals, Inc. (AGIO)



Trade AGIO now with
  Date
  Headline
9/16/2022 7:30:50 AM Agios Gets Positive CHMP Opinion For PYRUKYND For Treatment Of Pyruvate Kinase Deficiency In Adults
8/15/2022 8:03:44 AM Agios Appoints Rahul Ballal And Cynthia Smith To Board
7/12/2022 4:09:31 PM Agios Pharma Appoints Brian Goff As CEO
2/18/2022 12:23:53 AM Agios Pharma: FDA Approves Pyrukynd For Hemolytic Anemia In Adults With Pyruvate Kinase Deficiency
4/1/2021 7:17:35 AM Agios Closes Sale Of Commercial, Clinical And Research-stage Oncology Portfolio To Servier
6/13/2016 9:34:48 AM Canaccord Ups Agios Pharmaceuticals, Inc. (AGIO) To Buy From Hold With $90 Up From $50 Price Target
3/4/2016 10:22:52 AM Canaccord Is Lowering Agios Pharmaceuticals, Inc. (AGIO) 2016 Rev. Estimate To 84 M From 119 M
3/4/2016 10:21:31 AM Canaccord Is Cutting Agios Pharmaceuticals, Inc. (AGIO) 2016 Estimate To -3.73 From -2.10